MedCity News

CareValidate Launches Expanded HRT Offering

Lycia Lands a $317M IPO for Inflammation Drugs Based on Nobel Prize-Winning Science

Lycia Therapeutics’ protein-degrading drugs are based on the research of Carolyn Bertozzi, a Stanford chemistry professor and Nobel laureate. Lycia’s lead drug candidate is in development for food allergy, where it could compete against the blockbuster Roche drug Xolair.

By Frank Vinluan

MedCity Influencers, Hospitals

Congress’s Patient Matching Fix Won’t Work — Here’s What Would

The MATCH IT Act aims to reduce patient matching errors. But a model used by vital records systems could provide a better solution.

By Nidhi Singh

MedCity Influencers

Physician Mental Health and Health System Privacy: Why Doctors Avoid Their Own EHR

In most organizations the default access model was built for patient care, not for protecting colleagues. A nurse on another unit, a resident who rotated with them, a department administrator: any of them may technically be able to open the record, even when policy says they should not.

By Elijah Fernandez

Latest Video

Latest News

MedCity Influencers

A Radical Proposal to Preserve Cell and Gene Therapy Innovation

Cell and gene therapies are amazing medical breakthroughs but if we don’t find ways to pay for them, the development pipeline will fail.

By William Shrank

Hospitals, Physicians

Report: Health System M&A Activity Remains Steady in Third Quarter

A new report on third quarter M&A activity in the healthcare sector found that this quarter’s hospital and health system transactions remained steady, with 2026 potentially set to be a top year for total annual transactions since pre-pandemic times.

By Jenna Congdon

Devices & Diagnostics, Policy

AdvaMed’s 4 Policy Priorities, According to Its CEO

AdvaMed CEO Scott Whitaker outlined four policy priorities at the MedTech Conference: tariffs, FDA user fees, payment and coverage, and cybersecurity.

By Marissa Plescia

BioPharma, Pharma

Merck KGaA’s $1.1B Silence Therapeutics Buyout Brings RNA Drug for Rare Blood Cancer

The Silence Therapeutics acquisition gives Merck KGaA a drug ready for a pivotal test in the blood disorder polycythemia vera. Silence’s RNA therapy offers a different approach and a potential dosing advantage over a Takeda Pharmaceutical product recently approved in this indication.

By Frank Vinluan

Devices & Diagnostics

With $5M, Phantom GI Plans to Develop Minimally Invasive Alternative Ostomy Surgery Device

Phantom GI, a Tel Aviv-based medical startup, is developing the PercStoma device, a minimally invasive alternative to traditional ostomy surgery. The device would target patients with bowel obstructions who might otherwise be considered ineligible for surgery.

By Jenna Congdon

MedCity Influencers

Diagnosis Is Beside the Point

Some of the thorniest problems in medicine that AI can improve have nothing to do with diagnosis. They have to do with triage.

By Michael Choma

BioPharma, Startups

Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder

OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But Vertex Pharmaceuticals could also compete with a drug candidate from a recent acquisition.

By Frank Vinluan

The Hidden Administrative Tasks Draining Small Practices

Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.

By Michael Blackman, MD, MBA Chief Medical Officer, Greenway Health®

Health Tech

Allswell Raises $7M to Grow LGBTQ+ Behavioral Health Platform

Allswell's seed round was led by Rethink Impact, and included participation from Magnify Ventures, Ulu Ventures and Hopelab Ventures, joining existing investors Techstars and Amboy Street Ventures.

By Marissa Plescia

MedCity Influencers

The Antibiotics Exist —The System Cannot Deliver Them

This is not a discovery problem. It is a market entry and access problem, and it is far more tractable than the pipeline crisis we spend most of our attention on.

By Mallika Auplish and Diane Shader Smith

MedCity Influencers

Exercise is Prescribed Like Advice When It Should Be Delivered Like Treatment

Health care routinely recommends movement without providing assessment, dosage, progression, and follow-up that turn good advice into usable care.

By Pradeepika Samagh

Artificial Intelligence, Physicians

UPMC Enterprises Invests in VeloSource to Expand AI-Enabled Clinician Staffing Platform

UPMC Enterprises is making a strategic investment in VeloSource with plans to further develop its AI-enabled staffing management platform.

By Jenna Congdon

Health Tech

Why Epic Is Launching a Prescription Price Comparison Tool

Epic will launch a tool in summer 2027 to help patients compare prescription cash prices and insurance costs across pharmacies.

By Marissa Plescia

BioPharma, Pharma

City Therapeutics’ Upsized IPO Raises $200M to Bring RNAi Drugs Beyond the Liver

City Therapeutics’ lead RNA interference therapy could become an alternative to blockbuster-selling anticoagulants. The company’s technology for designing RNAi drugs and delivering them to tissues throughout the body has already led to partnerships with Bausch + Lomb in eye diseases and Biogen in central nervous system disorders.

By Frank Vinluan

MedCity Influencers

A dynamic 3D illustration featuring a long, curved arrow with focus circles along its path, each marked with a check signifying approval and progress. On both sides of the arrow are 3D mechanical gears, also containing check marks at their centers. This design symbolizes process flow, efficiency, and successful task completion. The interconnection of the arrow and gears visually conveys the seamless interaction and synchronization of components in a workflow. Ideal for concepts such as project management, quality assurance, and operational excellence, the design's modern aesthetic and bold 3D elements make it visually compelling and informative.

The Impending End of Cross-Subsidization

There is no single solution to the cross-subsidization problem. But here are some strategic actions that can make a health system’s economics more sustainable.

By Jeff Goldsmith and Brian Fisher

MedCity Influencers

How AI Is Connecting MedTech’s Data Without Compromising Compliance

The connected, agent-ready enterprise is the model that wins, where compliance and intelligence operate together.

By Chuck Serrin